肠-脑轴
内分泌系统
炎症
微生物群
肠道菌群
医学
小胶质细胞
疾病
炎症性肠病
全身炎症
生物信息学
内科学
免疫学
生物
激素
作者
Olivia Sullivan,Claire Sie,Katharine M. Ng,Sophie Cotton,Cal Rosete,Jordan E. Hamden,Ajay Paul Singh,Kristen Lee,Jatin Choudhary,Jennifer A. Kim,Huaxu Yu,Charlotte A. Clayton,Natalia A Carranza Garcia,Kateryna Voznyuk,Bohan Deng,Nadine Plett,Sana Arora,Hans Ghezzi,Tao Huan,Kiran K. Soma
标识
DOI:10.1016/j.bbi.2024.12.003
摘要
Despite recent advances in understanding the connection between the gut microbiota and the adult brain, there remains a wide knowledge gap in how gut inflammation impacts brain development. We hypothesized that intestinal inflammation in early life would negatively affect neurodevelopment through dysregulation of microbiota communication to the brain. We therefore developed a novel pediatric chemical model of inflammatory bowel disease (IBD), an incurable condition affecting millions of people worldwide. IBD is characterized by chronic intestinal inflammation, and has comorbid symptoms of anxiety, depression and cognitive impairment. Significantly, 25% of patients with IBD are diagnosed during childhood, and the effect of chronic inflammation during this critical period of development is largely unknown. This study investigated the effects of early-life gut inflammation induced by DSS (dextran sulfate sodium) on a range of microbiota, endocrine, and behavioral outcomes, focusing on sex-specific impacts. DSS-treated mice exhibited increased intestinal inflammation, altered microbiota membership, and changes in microbiota-mediated circulating metabolites. The majority of behavioral measures were unaffected, with the exception of impaired mate-seeking behaviors in DSS-treated males. DSS-treated males also showed significantly smaller seminal vesicles, lower circulating androgens, and decreased intestinal hormone-activating enzyme activity. In the brain, microglia morphology was chronically altered with DSS treatment in a sex-specific manner. The results suggest that early-life gut inflammation causes changes in gut microbiota composition, affecting short-chain fatty acid (SCFA) producers and glucuronidase (GUS) activity, correlating with altered SCFA and androgen levels. The findings emphasize the developmental sensitivity to inflammation-induced changes in endocrine signalling and underscore long-lasting physiological and microbiome changes associated with juvenile IBD.
科研通智能强力驱动
Strongly Powered by AbleSci AI